Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer

2018 ◽  
Vol 25 (11) ◽  
pp. 3288-3299 ◽  
Author(s):  
Yusuke Ishibashi ◽  
Hironori Tsujimoto ◽  
Shuichi Hiraki ◽  
Isao Kumano ◽  
Yoshihisa Yaguchi ◽  
...  
2018 ◽  
Vol 43 (12) ◽  
pp. 887-894 ◽  
Author(s):  
Sangwon Han ◽  
Yeon Joo Kim ◽  
Sungmin Woo ◽  
Chong Hyun Suh ◽  
Jong Jin Lee

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Zhenhua Liu ◽  
Hongtai Shi ◽  
Longyun Chen

Abstract Background In recent years, the role of pre-treatment C-reactive protein/albumin ratio (CAR) in prognosis of esophageal cancer (EC) has been investigated by several studies. This meta-analysis aimed to provide a more accurate and objective assessment of the prognostic value of pre-treatment CAR in EC. Methods Studies assessing the role of pre-treatment CAR in prognosis of EC were searched from PubMed, Embase and the Cochrane Library (last update by April 16, 2019). The hazard ratios (HRs) of CAR and the corresponding 95% CIs for overall survival (OS) or cancer-specific survival (CSS) in EC were extracted for pooled analysis. Results A total of eight observational studies including 2255 patients were collected. The pooled analysis showed that high CAR was related to worse OS in EC (pooled HR = 1.81; 95% CI = 1.40–2.35; P < 0.001). Subgroup analyses showed that the negative correlation between the CAR and OS was consistently demonstrated in subgroups stratified by country, pathological type, and cut-off value (P < 0.05). However, there was no relation between CAR and OS in subgroup of patients receiving neoadjuvant chemotherapy at a proportion of 100% (HR = 1.15, 95% CI = 0.56–2.69; P = 0.715). In addition, high CAR was also related to worse CSS in EC (pooled HR = 2.61; 95% CI = 1.67–4.06; P < 0.001). Conclusions High pre-treatment CAR was an adverse prognostic factor for EC patients. More large-sample clinical trials are still needed to verify the prognostic value of pre-treatment CAR in EC.


2019 ◽  
Vol Volume 11 ◽  
pp. 8181-8190
Author(s):  
Yan Wang ◽  
Pengfei Li ◽  
Jue Li ◽  
Yutian Lai ◽  
Kun Zhou ◽  
...  

2015 ◽  
Vol 112 (6) ◽  
pp. 597-602 ◽  
Author(s):  
Aaron U. Blackham ◽  
Binglin Yue ◽  
Khaldoun Almhanna ◽  
Nadia Saeed ◽  
Jacques P. Fontaine ◽  
...  

2012 ◽  
Vol 84 (3) ◽  
pp. S307-S308
Author(s):  
K. Atsumi ◽  
K. Nakamura ◽  
Y. Shioyama ◽  
K. Abe ◽  
T. Sasaki ◽  
...  

2011 ◽  
Vol 253 (2) ◽  
pp. 279-284 ◽  
Author(s):  
Hiroshi Miyata ◽  
Makoto Yamasaki ◽  
Shuji Takiguchi ◽  
Kiyokazu Nakajima ◽  
Yoshiyuki Fujiwara ◽  
...  

2016 ◽  
Vol 34 (4_suppl) ◽  
pp. 150-150
Author(s):  
Puja Venkat ◽  
Jasmine A Oliver ◽  
Will Jin ◽  
Joshua Dault ◽  
Jessica M. Frakes ◽  
...  

150 Background: The prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) has not yet been defined in locally advanced esophageal cancer (LAEC). This study aims to elucidate the prognostic role of PET/CT for patients treated with neoadjuvant chemoradiation (CRT) followed by esophagectomy. Methods: We retrospectively evaluated patients with LAEC treated from 2006 to 2014 with neoadjuvant CRT followed by esophagectomy. 86 patients had pre-CRT and post CRT PET/CT scans performed at our institution. These scans were imported into an image analysis program. PET parameters maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), mean standardized uptake value (SUVmean), and peak standardized uptake value (SUVpeak) were recorded for both pre-CRT and post-CRT scans. MTV was defined using a previously described liver method. The correlation of these parameters with pathologic complete response (pCR) and clinical outcomes was analyzed using binomial logistic regression and cox regression. Results: Pre-CRT MTV < 33.6 (median value) was significantly predictive of pCR (p = 0.019, OR = 3.064). An ROC curve was produced to determine a binary cutoff of 35.8, yielding a higher specificity (62.3% vs. 59%) and the same sensitivity (72.7%), increasing the significance to p = 0.010, OR = 3.378. The ratio of postMTV/preMTV (MTVr) was calculated. MTVr > 0.2857 (median value) was significantly predictive of distant metastasis (DM) after esophagectomy (p = 0.018, OR = 3.680). An ROC curve was produced to determine a binary cutoff of 0.301, which increased specificity from 57.1% to 60.3%, and maintained the same sensitivity at 81.3%, increasing the significance to p = 0.014, OR = 3.815. SUVmax, mean and peak were not predictive. Conclusions: Pre CRT MTV was predictive of pCR and MTVr was predictive of DM. Our data suggests that MTV is superior to SUVmax, mean and peak in predicting for response to treatment in LAEC. Further study is needed to determine if Pre CRT MTV and change in MTV can help define which patients will most benefit from esophagectomy and/ or adjuvant chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document